<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Mucopolysaccharidosis - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "‚Ü≥ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Mucopolysaccharidosis</span>
        </nav>

        <header class="page-header">
            <h1>Mucopolysaccharidosis</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Mendelian</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0019249" target="_blank">
                        MONDO:0019249
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Metabolic Bone Disorders</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Lysosomal Storage Disorders</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by deficiency of enzymes required for degradation of glycosaminoglycans (GAGs). Undegraded GAGs accumulate in lysosomes and extracellular matrix, causing progressive multisystem disease. Skeletal manifestations (dysostosis multiplex) are a unifying feature across all MPS types, including vertebral abnormalities, joint contractures, short stature, and characteristic radiographic changes. Enzyme replacement therapy and hematopoietic stem cell transplantation are available for several subtypes.

            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <a class="stat-link" href="#inheritance">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Inheritance</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        
        <div class="card" id="inheritance">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #92400e;">üë™</div>
                <h2 class="card-title">Inheritance</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box inheritance-box">
                <div class="item-name">
                    Autosomal Recessive
                    
                </div>
                
                <div class="item-desc">All MPS types are autosomal recessive except MPS II (Hunter syndrome), which is X-linked recessive.
</div>
                
                
    
    
    
    
                
    
    
            </div>
            
        </div>
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Lysosomal GAG Accumulation</div>
                
                <div class="item-desc">Deficiency of specific lysosomal enzymes leads to accumulation of undegraded glycosaminoglycans (dermatan sulfate, heparan sulfate, keratan sulfate, chondroitin sulfate, or hyaluronan depending on the subtype). GAGs accumulate in lysosomes of connective tissue cells, causing cellular dysfunction and tissue/organ damage. In bone and cartilage, GAG storage disrupts endochondral ossification, growth plate organization, and articular cartilage integrity.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Chondrocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000138" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Glycosaminoglycan Catabolism
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006027" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Lysosomal Transport
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007041" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-component">
                        Lysosome
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005764" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mucopolysaccharidoses are rare paediatric lysosomal storage disorders, characterised by accumulation of glycosaminoglycans within lysosomes"</div>
                
                
                <div class="evidence-explanation">Confirms MPS as lysosomal storage disorders with GAG accumulation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"caused by deficiencies in lysosomal enzymes involved in degradation of these molecules"</div>
                
                
                <div class="evidence-explanation">Confirms enzyme deficiency as the underlying cause of GAG accumulation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32780955" target="_blank">PMID:32780955</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder, caused by deficiency of Œ±-L-iduronidase, and consequent accumulation of dermatan and heparan sulfates"</div>
                
                
                <div class="evidence-explanation">Specific example of enzyme deficiency (alpha-L-iduronidase) causing GAG accumulation in MPS I.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Secondary Inflammatory Response</div>
                
                <div class="item-desc">Accumulated GAGs and their fragments activate toll-like receptors (TLR4) and inflammasome pathways, driving chronic inflammation that contributes to joint destruction, cardiac valve disease, and neurodegeneration. GAG-mediated inflammation amplifies tissue damage beyond direct storage effects.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Inflammatory Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We propose a model whereby progressive accumulation of glycosaminoglycans elicits an innate immune response, initiated by the Toll-like receptor 4 pathway"</div>
                
                
                <div class="evidence-explanation">Proposes TLR4-mediated innate immune activation by accumulated GAGs as key secondary mechanism.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"While TNF-Œ± is mostly associated with bone and joint disease in mucopolysaccharidoses, increasing evidence implicates IL-1 as a main effector of innate immunity in the central nervous system"</div>
                
                
                <div class="evidence-explanation">Distinguishes inflammatory mediators: TNF-alpha drives skeletal disease, IL-1 drives CNS inflammation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"progressive build-up of sugars may lead to musculoskeletal abnormalities and multi-organ failure, and in others, to cognitive decline"</div>
                
                
                <div class="evidence-explanation">GAG accumulation leads to progressive multisystem damage including musculoskeletal and cognitive decline.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">8</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Eye<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Head and Neck<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Musculoskeletal<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Nervous System<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Growth<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hepatosplenomegaly
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001433" target="_blank">
                                Hepatosplenomegaly
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001433)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ERT is effective in reducing urinary glycosaminoglycans (GAGs) and liver and spleen volume"</div>
                
                
                <div class="evidence-explanation">Hepatosplenomegaly is a recognized MPS feature that responds to ERT, confirming organ enlargement from GAG storage.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Cardiac Valve Disease
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001654" target="_blank">
                                Abnormal heart valve morphology
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001654)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Corneal Clouding
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0007957" target="_blank">
                                Corneal opacity
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0007957)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"cartilaginous organs such as the trachea and bronchi, bones and eyes are poorly impacted by ERT probably due to limited penetration in the specific tissue"</div>
                
                
                <div class="evidence-explanation">Corneal and ocular involvement in MPS is poorly responsive to ERT due to limited tissue penetration.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Head and Neck
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Coarse Facial Features
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000280" target="_blank">
                                Coarse facial features
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000280)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Musculoskeletal
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dysostosis Multiplex
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000943" target="_blank">
                                Dysostosis multiplex
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000943)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32780955" target="_blank">PMID:32780955</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A prominent clinical manifestation of MPS-IH is dysostosis multiplex, a constellation of skeletal abnormalities"</div>
                
                
                <div class="evidence-explanation">Confirms dysostosis multiplex as a prominent skeletal manifestation of MPS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Joint Contractures
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001387" target="_blank">
                                Joint stiffness
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001387)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"progressive build-up of sugars may lead to musculoskeletal abnormalities and multi-organ failure"</div>
                
                
                <div class="evidence-explanation">Musculoskeletal abnormalities from GAG storage include progressive joint stiffness and contractures.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Intellectual Disability
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001249" target="_blank">
                                Intellectual disability
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001249)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ERT in the present formulations also does not cross the blood-brain barrier, with the consequence that the central nervous system is not cured by ERT"</div>
                
                
                <div class="evidence-explanation">CNS involvement causing intellectual disability is a major challenge as ERT cannot cross the blood-brain barrier.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35216110" target="_blank">PMID:35216110</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"in others, to cognitive decline, which is still a challenge for current therapies"</div>
                
                
                <div class="evidence-explanation">Cognitive decline is a characteristic feature that remains a therapeutic challenge in MPS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25624320" target="_blank">PMID:25624320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Preservation of cognitive function at HCT and a younger age at transplantation were major predictors for superior cognitive development posttransplant"</div>
                
                
                <div class="evidence-explanation">Cognitive decline is a major concern in MPS I-H; early HCT can preserve cognitive function.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Growth
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Short Stature
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0004322" target="_blank">
                                Short stature
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0004322)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25624320" target="_blank">PMID:25624320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mucopolysaccharidosis type I-Hurler syndrome (MPS-IH) is a lysosomal storage disease characterized by multisystem morbidity and death in early childhood"</div>
                
                
                <div class="evidence-explanation">Multisystem morbidity in MPS I-H includes growth failure contributing to short stature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MPS I (IDUA Mutations)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32780955" target="_blank">PMID:32780955</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"caused by deficiency of Œ±-L-iduronidase, and consequent accumulation of dermatan and heparan sulfates"</div>
                
                
                <div class="evidence-explanation">Confirms alpha-L-iduronidase deficiency as the cause of MPS I with dermatan and heparan sulfate accumulation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32780955" target="_blank">PMID:32780955</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Severity of the disease ranges from mild (Scheie) to moderate (Hurler-Scheie) to severe (Hurler or MPS-IH)"</div>
                
                
                <div class="evidence-explanation">Confirms the clinical severity spectrum of MPS I from Scheie to Hurler.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MPS II (IDS Mutations)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This is particularly important for severe forms of MPS I and MPS II characterized by cognitive decline"</div>
                
                
                <div class="evidence-explanation">Confirms MPS II has severe forms with cognitive decline.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MPS IV (GALNS/GLB1 Mutations)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Enzyme Replacement Therapy
                    
                </div>
                
                
                <div class="item-desc">Intravenous recombinant enzyme infusions for MPS I (laronidase), MPS II (idursulfase), MPS IVA (elosulfase alfa), MPS VI (galsulfase), and MPS VII (vestronidase alfa). Improves somatic features but does not cross the blood-brain barrier effectively.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Enzyme replacement therapy (ERT) is available for mucopolysaccharidosis (MPS) I, MPS II, MPS VI, and MPS IVA"</div>
                
                
                <div class="evidence-explanation">Confirms ERT availability for MPS I, II, VI, and IVA.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ERT is effective in reducing urinary glycosaminoglycans (GAGs) and liver and spleen volume, cartilaginous organs such as the trachea and bronchi, bones and eyes are poorly impacted by ERT probably due to limited penetration in the specific tissue"</div>
                
                
                <div class="evidence-explanation">ERT is effective for some features but has limited impact on cartilage, bones, and eyes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ERT in the present formulations also does not cross the blood-brain barrier, with the consequence that the central nervous system is not cured by ERT"</div>
                
                
                <div class="evidence-explanation">Major limitation of ERT is inability to cross the blood-brain barrier for CNS disease.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Hematopoietic Stem Cell Transplantation
                    
                </div>
                
                
                <div class="item-desc">HSCT provides a permanent source of enzyme-producing donor cells. Most effective when performed before age 2 in MPS I-H (Hurler). Can stabilize neurocognitive outcomes by providing CNS enzyme via donor-derived microglia.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30442189" target="_blank">PMID:30442189</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"For severe MPS I patients (Hurler), early haematopoietic stem cell transplantation is the gold standard"</div>
                
                
                <div class="evidence-explanation">Confirms HSCT as gold standard for severe MPS I.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25624320" target="_blank">PMID:25624320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Two hundred seventeen patients with MPS-IH successfully engrafted with a median follow-up age of 9.2 years were included in this retrospective analysis"</div>
                
                
                <div class="evidence-explanation">Large multicenter study of 217 HCT patients demonstrates long-term outcomes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25624320" target="_blank">PMID:25624320</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Considerable residual disease burden was observed in the majority of the transplanted patients with MPS-IH, with high variability between patients"</div>
                
                
                <div class="evidence-explanation">Despite HCT, substantial residual disease burden persists, highlighting limitations of current treatment.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive Orthopedic Care
                    
                </div>
                
                
                <div class="item-desc">Spinal surgery for cervical instability (especially MPS IV), joint replacement, carpal tunnel release, and management of kyphosis and scoliosis.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32780955" target="_blank">PMID:32780955</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"thoracolumbar kyphosis is an early manifestation in humans"</div>
                
                
                <div class="evidence-explanation">Early skeletal manifestations like thoracolumbar kyphosis require orthopedic monitoring and intervention.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Mucopolysaccharidosis
creation_date: &#39;2026-02-13T00:31:42Z&#39;
updated_date: &#39;2026-02-17T21:53:14Z&#39;
category: Mendelian
description: &gt;
  The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused
  by deficiency of enzymes required for degradation of glycosaminoglycans (GAGs).
  Undegraded GAGs accumulate in lysosomes and extracellular matrix, causing
  progressive multisystem disease. Skeletal manifestations (dysostosis multiplex)
  are a unifying feature across all MPS types, including vertebral abnormalities,
  joint contractures, short stature, and characteristic radiographic changes.
  Enzyme replacement therapy and hematopoietic stem cell transplantation are
  available for several subtypes.
disease_term:
  preferred_term: Mucopolysaccharidosis
  term:
    id: MONDO:0019249
    label: mucopolysaccharidosis
parents:
- Metabolic Bone Disorders
- Lysosomal Storage Disorders
inheritance:
- name: Autosomal Recessive
  description: &gt;
    All MPS types are autosomal recessive except MPS II (Hunter syndrome),
    which is X-linked recessive.
pathophysiology:
- name: Lysosomal GAG Accumulation
  description: &gt;
    Deficiency of specific lysosomal enzymes leads to accumulation of
    undegraded glycosaminoglycans (dermatan sulfate, heparan sulfate,
    keratan sulfate, chondroitin sulfate, or hyaluronan depending on
    the subtype). GAGs accumulate in lysosomes of connective tissue
    cells, causing cellular dysfunction and tissue/organ damage. In
    bone and cartilage, GAG storage disrupts endochondral ossification,
    growth plate organization, and articular cartilage integrity.
  biological_processes:
  - preferred_term: Glycosaminoglycan Catabolism
    term:
      id: GO:0006027
      label: glycosaminoglycan catabolic process
  - preferred_term: Lysosomal Transport
    term:
      id: GO:0007041
      label: lysosomal transport
  cellular_components:
  - preferred_term: Lysosome
    term:
      id: GO:0005764
      label: lysosome
  cell_types:
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  evidence:
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;Mucopolysaccharidoses are rare paediatric lysosomal storage disorders,
      characterised by accumulation of glycosaminoglycans within lysosomes&#34;
    explanation: &#34;Confirms MPS as lysosomal storage disorders with GAG accumulation.&#34;
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;caused by deficiencies in lysosomal enzymes involved in degradation
      of these molecules&#34;
    explanation: &#34;Confirms enzyme deficiency as the underlying cause of GAG accumulation.&#34;
  - reference: PMID:32780955
    supports: SUPPORT
    snippet: &#34;Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder,
      caused by deficiency of Œ±-L-iduronidase, and consequent accumulation of dermatan
      and heparan sulfates&#34;
    explanation: &#34;Specific example of enzyme deficiency (alpha-L-iduronidase) causing
      GAG accumulation in MPS I.&#34;
- name: Secondary Inflammatory Response
  description: &gt;
    Accumulated GAGs and their fragments activate toll-like receptors
    (TLR4) and inflammasome pathways, driving chronic inflammation
    that contributes to joint destruction, cardiac valve disease,
    and neurodegeneration. GAG-mediated inflammation amplifies
    tissue damage beyond direct storage effects.
  biological_processes:
  - preferred_term: Inflammatory Response
    term:
      id: GO:0006954
      label: inflammatory response
  evidence:
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;We propose a model whereby progressive accumulation of glycosaminoglycans
      elicits an innate immune response, initiated by the Toll-like receptor 4 pathway&#34;
    explanation: &#34;Proposes TLR4-mediated innate immune activation by accumulated GAGs
      as key secondary mechanism.&#34;
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;While TNF-Œ± is mostly associated with bone and joint disease in mucopolysaccharidoses,
      increasing evidence implicates IL-1 as a main effector of innate immunity in
      the central nervous system&#34;
    explanation: &#34;Distinguishes inflammatory mediators: TNF-alpha drives skeletal
      disease, IL-1 drives CNS inflammation.&#34;
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;progressive build-up of sugars may lead to musculoskeletal abnormalities
      and multi-organ failure, and in others, to cognitive decline&#34;
    explanation: &#34;GAG accumulation leads to progressive multisystem damage including
      musculoskeletal and cognitive decline.&#34;
phenotypes:
- name: Dysostosis Multiplex
  description: &gt;
    Characteristic skeletal radiographic pattern common to all MPS types,
    including J-shaped sella turcica, oar-shaped ribs, bullet-shaped
    vertebral bodies with anterior beaking, proximal metacarpal pointing,
    and flared iliac wings. Severity varies by subtype.
  phenotype_term:
    preferred_term: Dysostosis multiplex
    term:
      id: HP:0000943
      label: Dysostosis multiplex
  evidence:
  - reference: PMID:32780955
    supports: SUPPORT
    snippet: &#34;A prominent clinical manifestation of MPS-IH is dysostosis multiplex,
      a constellation of skeletal abnormalities&#34;
    explanation: &#34;Confirms dysostosis multiplex as a prominent skeletal manifestation
      of MPS.&#34;
- name: Short Stature
  description: &gt;
    Progressive growth failure due to disrupted endochondral ossification
    and growth plate dysfunction. Most severe in MPS I-H (Hurler),
    MPS IV (Morquio), and MPS VI (Maroteaux-Lamy).
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:25624320
    supports: SUPPORT
    snippet: &#34;Mucopolysaccharidosis type I-Hurler syndrome (MPS-IH) is a lysosomal
      storage disease characterized by multisystem morbidity and death in early childhood&#34;
    explanation: &#34;Multisystem morbidity in MPS I-H includes growth failure contributing
      to short stature.&#34;
- name: Joint Contractures
  description: &gt;
    Progressive joint stiffness and contractures from GAG storage in
    periarticular tissues. Present in most MPS types except MPS IV
    (Morquio), which features joint laxity instead.
  phenotype_term:
    preferred_term: Joint stiffness
    term:
      id: HP:0001387
      label: Joint stiffness
  evidence:
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;progressive build-up of sugars may lead to musculoskeletal abnormalities
      and multi-organ failure&#34;
    explanation: &#34;Musculoskeletal abnormalities from GAG storage include progressive
      joint stiffness and contractures.&#34;
- name: Coarse Facial Features
  description: &gt;
    Progressive coarsening of facial features from GAG infiltration
    of soft tissues, including broad nasal bridge, thick lips,
    macroglossia, and frontal bossing.
  phenotype_term:
    preferred_term: Coarse facial features
    term:
      id: HP:0000280
      label: Coarse facial features
- name: Hepatosplenomegaly
  description: &gt;
    Enlargement of liver and spleen from GAG storage in
    reticuloendothelial cells.
  phenotype_term:
    preferred_term: Hepatosplenomegaly
    term:
      id: HP:0001433
      label: Hepatosplenomegaly
  evidence:
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;ERT is effective in reducing urinary glycosaminoglycans (GAGs) and liver
      and spleen volume&#34;
    explanation: &#34;Hepatosplenomegaly is a recognized MPS feature that responds to
      ERT, confirming organ enlargement from GAG storage.&#34;
- name: Cardiac Valve Disease
  description: &gt;
    Progressive thickening and dysfunction of cardiac valves from
    GAG infiltration. Mitral and aortic valves most commonly affected.
  phenotype_term:
    preferred_term: Abnormal heart valve morphology
    term:
      id: HP:0001654
      label: Abnormal heart valve morphology
- name: Corneal Clouding
  description: &gt;
    Corneal opacification from GAG deposition in the corneal stroma.
    Characteristic of MPS I, IV, VI, and VII.
  phenotype_term:
    preferred_term: Corneal opacity
    term:
      id: HP:0007957
      label: Corneal opacity
  evidence:
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;cartilaginous organs such as the trachea and bronchi, bones and eyes
      are poorly impacted by ERT probably due to limited penetration in the specific
      tissue&#34;
    explanation: &#34;Corneal and ocular involvement in MPS is poorly responsive to ERT
      due to limited tissue penetration.&#34;
- name: Intellectual Disability
  description: &gt;
    Neurocognitive decline from CNS GAG accumulation (heparan sulfate).
    Prominent in MPS I-H, II (severe), and III (Sanfilippo).
    Absent in MPS IV and VI.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;ERT in the present formulations also does not cross the blood-brain
      barrier, with the consequence that the central nervous system is not cured by
      ERT&#34;
    explanation: &#34;CNS involvement causing intellectual disability is a major challenge
      as ERT cannot cross the blood-brain barrier.&#34;
  - reference: PMID:35216110
    supports: SUPPORT
    snippet: &#34;in others, to cognitive decline, which is still a challenge for current
      therapies&#34;
    explanation: &#34;Cognitive decline is a characteristic feature that remains a therapeutic
      challenge in MPS.&#34;
  - reference: PMID:25624320
    supports: SUPPORT
    snippet: &#34;Preservation of cognitive function at HCT and a younger age at transplantation
      were major predictors for superior cognitive development posttransplant&#34;
    explanation: &#34;Cognitive decline is a major concern in MPS I-H; early HCT can preserve
      cognitive function.&#34;
genetic:
- name: MPS I (IDUA Mutations)
  association: Causative
  notes: &gt;
    Alpha-L-iduronidase deficiency. Spectrum from severe Hurler (MPS I-H)
    to attenuated Scheie (MPS I-S). Dermatan and heparan sulfate accumulation.
  evidence:
  - reference: PMID:32780955
    supports: SUPPORT
    snippet: &#34;caused by deficiency of Œ±-L-iduronidase, and consequent accumulation
      of dermatan and heparan sulfates&#34;
    explanation: &#34;Confirms alpha-L-iduronidase deficiency as the cause of MPS I with
      dermatan and heparan sulfate accumulation.&#34;
  - reference: PMID:32780955
    supports: SUPPORT
    snippet: &#34;Severity of the disease ranges from mild (Scheie) to moderate (Hurler-Scheie)
      to severe (Hurler or MPS-IH)&#34;
    explanation: &#34;Confirms the clinical severity spectrum of MPS I from Scheie to
      Hurler.&#34;
- name: MPS II (IDS Mutations)
  association: Causative
  notes: &gt;
    Iduronate-2-sulfatase deficiency (Hunter syndrome). X-linked recessive.
    Dermatan and heparan sulfate accumulation. Severe and attenuated forms.
  evidence:
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;This is particularly important for severe forms of MPS I and MPS II
      characterized by cognitive decline&#34;
    explanation: &#34;Confirms MPS II has severe forms with cognitive decline.&#34;
- name: MPS IV (GALNS/GLB1 Mutations)
  association: Causative
  notes: &gt;
    Morquio syndrome. Type A (GALNS, N-acetylgalactosamine-6-sulfatase)
    and type B (GLB1, beta-galactosidase). Keratan sulfate accumulation.
    Distinctive for joint laxity rather than stiffness, and severe
    skeletal dysplasia with atlantoaxial instability.
treatments:
- name: Enzyme Replacement Therapy
  description: &gt;
    Intravenous recombinant enzyme infusions for MPS I (laronidase),
    MPS II (idursulfase), MPS IVA (elosulfase alfa), MPS VI
    (galsulfase), and MPS VII (vestronidase alfa). Improves somatic
    features but does not cross the blood-brain barrier effectively.
  evidence:
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;Enzyme replacement therapy (ERT) is available for mucopolysaccharidosis
      (MPS) I, MPS II, MPS VI, and MPS IVA&#34;
    explanation: &#34;Confirms ERT availability for MPS I, II, VI, and IVA.&#34;
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;ERT is effective in reducing urinary glycosaminoglycans (GAGs) and liver
      and spleen volume, cartilaginous organs such as the trachea and bronchi, bones
      and eyes are poorly impacted by ERT probably due to limited penetration in the
      specific tissue&#34;
    explanation: &#34;ERT is effective for some features but has limited impact on cartilage,
      bones, and eyes.&#34;
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;ERT in the present formulations also does not cross the blood-brain
      barrier, with the consequence that the central nervous system is not cured by
      ERT&#34;
    explanation: &#34;Major limitation of ERT is inability to cross the blood-brain barrier
      for CNS disease.&#34;
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;All patients develop anti-ERT antibodies but only a few have drug-related
      adverse reactions&#34;
    explanation: &#34;Immunogenicity is universal but rarely clinically significant.&#34;
- name: Hematopoietic Stem Cell Transplantation
  description: &gt;
    HSCT provides a permanent source of enzyme-producing donor cells.
    Most effective when performed before age 2 in MPS I-H (Hurler).
    Can stabilize neurocognitive outcomes by providing CNS enzyme
    via donor-derived microglia.
  evidence:
  - reference: PMID:30442189
    supports: SUPPORT
    snippet: &#34;For severe MPS I patients (Hurler), early haematopoietic stem cell transplantation
      is the gold standard&#34;
    explanation: &#34;Confirms HSCT as gold standard for severe MPS I.&#34;
  - reference: PMID:25624320
    supports: SUPPORT
    snippet: &#34;Two hundred seventeen patients with MPS-IH successfully engrafted with
      a median follow-up age of 9.2 years were included in this retrospective analysis&#34;
    explanation: &#34;Large multicenter study of 217 HCT patients demonstrates long-term
      outcomes.&#34;
  - reference: PMID:25624320
    supports: SUPPORT
    snippet: &#34;Considerable residual disease burden was observed in the majority of
      the transplanted patients with MPS-IH, with high variability between patients&#34;
    explanation: &#34;Despite HCT, substantial residual disease burden persists, highlighting
      limitations of current treatment.&#34;
  - reference: PMID:25624320
    supports: SUPPORT
    snippet: &#34;Preservation of cognitive function at HCT and a younger age at transplantation
      were major predictors for superior cognitive development posttransplant&#34;
    explanation: &#34;Early transplantation before cognitive decline is critical for optimal
      neurodevelopmental outcomes.&#34;
  - reference: PMID:25624320
    supports: SUPPORT
    snippet: &#34;A normal Œ±-l-iduronidase enzyme level obtained post-HCT was another
      highly significant predictor for superior long-term outcome in most organ systems&#34;
    explanation: &#34;Full donor chimerism with normal enzyme levels is essential for
      best long-term outcomes across organ systems.&#34;
- name: Supportive Orthopedic Care
  description: &gt;
    Spinal surgery for cervical instability (especially MPS IV),
    joint replacement, carpal tunnel release, and management of
    kyphosis and scoliosis.
  evidence:
  - reference: PMID:32780955
    supports: SUPPORT
    snippet: &#34;thoracolumbar kyphosis is an early manifestation in humans&#34;
    explanation: &#34;Early skeletal manifestations like thoracolumbar kyphosis require
      orthopedic monitoring and intervention.&#34;
datasets: []
references:
- reference: DOI:10.1016/j.isci.2024.108959
  title: Metabolic rewiring and autophagy inhibition correct lysosomal storage
    disease in mucopolysaccharidosis IIIB
  findings: []
- reference: DOI:10.3390/biomedicines11041067
  title: &#39;Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms
    of Neuroinflammation in Lysosomal Storage Diseases&#39;
  findings: []
- reference: DOI:10.3390/cimb46030169
  title: &#39;Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic
    Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases&#39;
  findings: []
- reference: DOI:10.3390/ijms25021113
  title: Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and
    Prospects for Innovative Therapy
  findings: []
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Mucopolysaccharidosis.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>